Yulan Deng
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Author Correction: A proteogenomic atlas of 1032 brain metastases identifies molecular subtypes, immune landscapes, and therapeutic vulnerabilities.
Journal: Nature communications
Published: April 15, 2026
A proteogenomic atlas of 1032 brain metastases identifies molecular subtypes, immune landscapes, and therapeutic vulnerabilities.
Journal: Nature communications
Published: September 10, 2025
TE-SCALE: a comprehensive database for exploring transposable element expression across human cancers at single-cell resolution.
Journal: Nucleic acids research
Published: August 15, 2025
A Comprehensive Proteogenomic and Spatial Analysis of Innate and Acquired Resistance of Metastatic Melanoma to Immune Checkpoint Blockade Therapies.
Journal: bioRxiv : the preprint server for biology
Published: September 24, 2024
Dynamic ctDNA informs whole-course postoperative precise management of NSCLC (LUNGCA study).
Journal: Journal of the National Cancer Institute
Published: September 22, 2024
Expression Pattern and Prognostic Analysis of Branched-Chain Amino Acid Catabolism-Related Genes in Non-Small Cell Lung Cancer.
Journal: Frontiers in bioscience (Landmark edition)
Published: October 21, 2022
Multicellular ecotypes shape progression of lung adenocarcinoma from ground-glass opacity toward advanced stages.
Journal: Cell reports. Medicine
Published: September 30, 2022
Systematic evaluation of tumor microenvironment and construction of a machine learning model to predict prognosis and immunotherapy efficacy in triple-negative breast cancer based on data mining and sequencing validation.
Journal: Frontiers in pharmacology
Published: July 16, 2022
Perioperative ctDNA-Based Molecular Residual Disease Detection for Non-Small Cell Lung Cancer: A Prospective Multicenter Cohort Study (LUNGCA-1).
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 22, 2021
Identifies Immune Feature Genes for Prediction of Chemotherapy Benefit in Cancer.
Journal: Journal of Cancer
Published: August 02, 2021
Tumor-Infiltrating PD-1hiCD8+-T-Cell Signature as an Effective Biomarker for Immune Checkpoint Inhibitor Therapy Response Across Multiple Cancers.
Journal: Frontiers in oncology
Published: April 14, 2021
Last Updated: 09/26/2026